Flex Biomedical Overview
- Year Founded
-
2007
- Status
-
Private
- Employees
-
2
- Latest Deal Type
-
2ndary - Private
- Investors
-
1
Flex Biomedical General Information
Description
Developer of novel treatments and diagnostics intended to cure orthopedic diseases. The company's diagnostics are based on synthetic polymer designed to treat osteoarthritis, an incurable joint disease that affects millions around the world, enabling patients to stay active and maintain the freedom of movement while minimizing pain.
Contact Information
Website
www.flexbio.comCorporate Office
- 555 D'Onofrio Drive
- Suite 102
- Madison, WI 53719
- United States
Corporate Office
- 555 D'Onofrio Drive
- Suite 102
- Madison, WI 53719
- United States
Flex Biomedical Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Secondary Transaction - Private | 01-Mar-2021 | Completed | Profitable | |||
| 7. Later Stage VC | 13-Sep-2013 | Completed | Profitable | |||
| 6. Early Stage VC | 13-Jun-2012 | Completed | Profitable | |||
| 5. Early Stage VC | 29-Aug-2011 | Completed | Profitable | |||
| 4. Early Stage VC | 27-Jan-2011 | Completed | Profitable | |||
| 3. Early Stage VC | 03-Nov-2010 | Completed | Profitable | |||
| 2. Grant | 02-Nov-2010 | $419K | $1.14M | Completed | Startup | |
| 1. Early Stage VC | 12-Jun-2009 | $1.14M | $1.14M | Completed | Startup |
Flex Biomedical Patents
Flex Biomedical Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2012102861-A1 | Polymer - active agent conjugates | Inactive | 24-Jan-2011 | ||
| US-20130344023-A1 | Polymer-active agent conjugates | Inactive | 24-Jan-2011 | ||
| WO-2012097078-A2 | Viscosupplementary materials | Inactive | 14-Jan-2011 | ||
| WO-2012097078-A3 | Viscosupplementary materials | Inactive | 14-Jan-2011 | A61L27/16 |
Flex Biomedical Signals
Flex Biomedical Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| National Institutes of Arthritis and Musculoskeletal Diseases | Not-For-Profit Venture Capital |
Flex Biomedical FAQs
-
When was Flex Biomedical founded?
Flex Biomedical was founded in 2007.
-
Where is Flex Biomedical headquartered?
Flex Biomedical is headquartered in Madison, WI.
-
What is the size of Flex Biomedical?
Flex Biomedical has 2 total employees.
-
What industry is Flex Biomedical in?
Flex Biomedical’s primary industry is Pharmaceuticals.
-
Is Flex Biomedical a private or public company?
Flex Biomedical is a Private company.
-
What is Flex Biomedical’s current revenue?
The current revenue for Flex Biomedical is .
-
How much funding has Flex Biomedical raised over time?
Flex Biomedical has raised $4.73M.
-
Who are Flex Biomedical’s investors?
National Institutes of Arthritis and Musculoskeletal Diseases has invested in Flex Biomedical.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process